Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,745.50
Bid: 1,745.00
Ask: 1,746.00
Change: -29.50 (-1.66%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,744.50
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATING CHANGES: Goldman Cuts RBS To Neutral From Buy

Tue, 12th Nov 2013 10:18

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Monday afternoon:
----------
FTSE 100
----------
NOMURA DOWNGRADES BRITISH SKY BROADCASTING GROUP PLC (BSY.L) TO REDUCE FROM BUY
----------
S&P CAPITAL IQ CUTS BSKYB TO 'SELL' ('BUY') - PRICE TARGET 700 (1050) PENCE
----------
CREDIT SUISSE CUTS BSKYB TO 'UNDERPERFORM' ('NEUTRAL') - PRICE TARGET 700 (810) PENCE
----------
UBS RAISES SMITHS GROUP PRICE TARGET TO 1000 (750) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RBS TO 'NEUTRAL' ('BUY') - TARGET 370 (400) PENCE
----------
NOMURA RAISES RBS PRICE TARGET TO 285 (270) PENCE - 'REDUCE'
----------
MACQUARIE REMOVES RBS FROM 'CONVICTION SELL LIST'
----------
JPMORGAN CUTS RSA INSURANCE TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 126 (140) P.
----------
NOMURA CUTS RSA INSURANCE PRICE TARGET TO 113 (120) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS ITV TO 'NEUTRAL' ('BUY') - TARGET 191 (180) PENCE
----------
PANMURE CUTS GLAXOSMITHKLINE TO 'HOLD' ('BUY') - TARGET 1,750 (1,850) PENCE
----------
SOCGEN RAISES SHIRE PRICE TARGET TO 3615 (3270) PENCE - 'BUY'
----------
MACQUARIE REMOVES IAG FROM 'CONVICTION BUY LIST' - 'OUTPERFORM'
----------
MORGAN STANLEY RAISES ROLLS-ROYCE PRICE TARGET TO 1400 (1300) P. - 'OVERWEIGHT'
----------
FTSE 250
----------
UBS CUTS BALFOUR BEATTY TO 'SELL' ('NEUTRAL') - TARGET 245 (220) PENCE
----------
UBS CUTS COBHAM PRICE TARGET TO 290 (305) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS COBHAM PRICE TARGET TO 270 (275) PENCE - 'HOLD'
----------
BARCLAYS INITIATES F&C ASSET MANAGEMENT WITH 'UNDERWEIGHT' - TARGET 90 PENCE
----------
CITIGROUP RAISES LONMIN PRICE TARGET TO 453 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LONMIN PRICE TARGET TO 390 (315) PENCE - 'HOLD'
----------
JPMORGAN RAISES LONMIN PRICE TARGET TO 430 (400) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES LONMIN PRICE TARGET TO 512 (485) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES HALFORDS GROUP PRICE TARGET TO 410 (330) PENCE - 'SELL'
----------
DEUTSCHE BANK RAISES WH SMITH PLC PRICE TARGET TO 1075 (960) PENCE - 'BUY'
----------
EXANE BNP RAISES SHAFTESBURY TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 580 PENCE
----------
NUMIS CUTS MENZIES(JOHN) TO 'HOLD' ('ADD') - TARGET 774 (834) PENCE
----------
PANMURE RAISES BTG PRICE TARGET TO 490 (450) PENCE - 'BUY'
----------
PANMURE RAISES RIGHTMOVE PRICE TARGET TO 3,130 (3,000) PENCE - 'BUY'
----------
CANACCORD RAISES CATLIN GROUP PRICE TARGET TO 550 (540) PENCE - 'BUY'
----------
NUMIS RAISES CATLIN GROUP TO 'HOLD' ('REDUCE') - TARGET 575 (420) PENCE
----------
JEFFERIES CUTS MORGAN ADVANCED MATERIALS PRICE TARGET TO 340 (345) PENCE- 'BUY'
----------
JEFFERIES RAISES RENTOKIL INITIAL PRICE TARGET TO 116 (104) PENCE - 'HOLD'
----------
NUMIS CUTS DIGNITY TO 'HOLD' ('ADD') - TARGET 1,575 (1,625) PENCE
----------
Numis Upgrades Oxford Instruments To Buy From Add, Price Target 1,600p
----------
ALL-SHARE AND AIM
----------
GOLDMAN RAISES SHANKS GROUP PRICE TARGET TO 128 (126) PENCE - 'BUY'
----------
CANACCORD CUTS CHESNARA PLC TO 'HOLD' ('BUY') - TARGET 300 (290) PENCE
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
Today 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
Today 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more
16 May 2024 16:54

LONDON MARKET CLOSE: Europe struggles but record highs in New York

(Alliance News) - Large-cap European equities closed lower on Thursday, underperforming New York counterparts, which continued to push higher following Wednesday's softer US inflation data.

Read more
16 May 2024 16:53

London close: Stocks mixed as ex-divs drag on FTSE

(Sharecast News) - London stocks ended mixed on Thursday, following a flurry of corporate news and a focus on US unemployment figures.

Read more
14 May 2024 10:11

LONDON BROKER RATINGS: DB and Berenberg raise Diploma price target

(Alliance News) - the following London-listed shares received analyst recommendations Monday and Tuesday morning:

Read more
13 May 2024 09:41

LONDON BROKER RATINGS: BAE Systems and Mondi cut to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.